Monalizumab (Anti-Human CD159a)

製品コード：A2053         Batch: A205302

印刷

Monalizumab (Anti-Human CD159a) is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors.

製品説明

CAS No. 1228763-95-8
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4-Kappa
Application Monalizumab (Anti-Human CD159a)
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 10.7mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。